PerpEquities

Guardant Health, Inc. (GH) balance sheet

NASDAQ · Healthcare · Medical - Diagnostics & Research · 2,498 employees · CEO Helmy Eltoukhy

Price
$145.83 +0.16%
Market cap
$19.7B
Enterprise value
$20.4B Data as of 2026-11-22
Last report
Q3 '26 filed 2026-11-05
Next report
2027-02-18 EPS est. -$0.75

At the end of Q3 '26 Guardant Health, Inc. (GH) held $1.03B in cash and short-term investments against $1.69B of debt incl. leases. Total assets $1.89B, total liabilities $2.16B, shareholders' equity -$276M.

Balance sheet

Balance sheetTrendQ4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Assets
Cash & equivalents$1.13B$1.13B$1.04B$688M$526M$699M$629M$580M$378M$989M$1.05B$1.03B
Short-term investments$35.1M$0$0$311M$314M$0$0$0$823M$113M$0$0
Receivables$88.8M$84.6M$101M$88.5M$110M$115M$130M$116M$138M$137M$144M$187M
Inventory$61.9M$63M$67M$72.3M$71.1M$77.3M$84.1M$90.5M$85.9M$83.9M$105M$93.5M
Other current assets$27.7M$31.7M$87.2M$66.9M$33.8M$35.8M$40M$42.8M$40.7M$43.5M$61.5M$0
Current assets$1.35B$1.31B$1.29B$1.23B$1.06B$927M$883M$829M$1.47B$1.37B$1.36B$1.34B
Property, plant & equipment (net)$303M$290M$278M$270M$279M$270M$296M$288M$305M$304M$303M$293M
Long-term investments$0$76.5M$11.1M$0$0$116M$122M$130M$0$0$121M$6.5M
Goodwill$3.29M$3.29M$3.29M$3.29M$3.29M$3.29M$3.29M$3.29M$77.3M$77.3M$77.3M$77.3M
Intangible assets$8.98M$8.29M$7.74M$7.25M$6.76M$6.28M$5.86M$5.48M$25.9M$25.5M$25.3M$25M
Other non-current assets$124M$17.7M$18.8M$31.3M$141M$21.5M$21.1M$21.4M$140M$141M$21.5M$141M
Non-current assets$439M$396M$319M$312M$430M$417M$449M$448M$548M$548M$548M$542M
Total assets$1.79B$1.7B$1.61B$1.54B$1.49B$1.34B$1.33B$1.28B$2.01B$1.92B$1.91B$1.89B
Liabilities
Accounts payable$51.7M$37.6M$42.4M$15.5M$38.6M$49.8M$44.8M$20.1M$54.4M$75M$93.5M$103M
Accrued expenses$35.5M$39.3M$43M$44.3M$39.1M$46.3M$44.7M$45.3M$50.2M$50M$0$204M
Deferred revenue$18M$22.6M$29.4M$29.6M$35.5M$36.3M$54.4M$46.9M$50.8M$47.8M$44.8M$38.1M
Other current liabilities$72.7M$92.6M$59.1M$80.6M$83.2M$63.7M$68.3M$98.2M$120M$91.3M$173M$0
Current liabilities$206M$220M$202M$197M$226M$226M$238M$237M$303M$292M$339M$373M
Long-term debt$1.14B$1.14B$1.14B$1.14B$1.14B$1.12B$1.12B$1.11B$1.5B$1.5B$1.5B$1.5B
Lease obligations (non-current)$186M$179M$172M$170M$164M$160M$192M$185M$178M$173M$166M$160M
Deferred revenue (non-current)$0$0$0$0$0$0$0$0$0$0$0$7M
Other non-current liabilities$96M$96.8M$95.9M$89.4M$92.8M$92.5M$91.2M$94.4M$128M$128M$127M$119M
Non-current liabilities$1.42B$1.42B$1.41B$1.4B$1.4B$1.37B$1.4B$1.39B$1.81B$1.8B$1.8B$1.79B
Total liabilities$1.63B$1.64B$1.61B$1.6B$1.63B$1.6B$1.64B$1.63B$2.11B$2.1B$2.14B$2.16B
Equity
Common stock & paid-in capital$1K$1K$1K$1K$1K$1K$1K$1K$1K$1K$1K$1K
Retained earnings-$2.14B-$2.26B-$2.36B-$2.47B-$2.58B-$2.67B-$2.77B-$2.87B-$2.99B-$3.11B-$3.23B-$3.35B
Accumulated other comprehensive income-$3.68M-$4.8M-$5.64M-$3.28M-$5.2M-$4.66M-$3.72M-$4.26M-$4.85M-$5.15M-$5.56M-$5.13M
Shareholders' equity$159M$68.3M-$1.61M-$60.1M-$140M-$251M-$305M-$354M-$99.3M-$181M-$223M-$276M
Debt
Total debt (incl. leases)$1.35B$1.35B$1.34B$1.34B$1.34B$1.31B$1.33B$1.33B$1.71B$1.7B$1.7B$1.69B
Net debt (debt - cash)$220M$218M$306M$651M$811M$608M$705M$746M$1.33B$715M$644M$665M

Standardised from the company's filings; outflows and costs keep the sign the provider reports. Hover a period for its end date. Amounts in USD.

Cash, investments and debt

quarter ends

The other statements

Sources

Statements, segment revenue, metrics and estimates are standardised from the company's filings. Segment profits and every reported line: SEC EDGAR (XBRL). Filings read: 10-Q 2026-09-30, 10-Q 2026-06-30, 10-Q 2026-03-31, 10-K 2025-12-31, 10-Q 2025-09-30, 10-Q 2025-06-30, 10-Q 2025-03-31, 10-K 2024-12-31, 10-Q 2024-09-30

Data as of 2026-11-22